Antitubercular nanocarrier monotherapy: Study of In Vivo efficacy and pharmacokinetics for rifampicin-Reference-Cited by-同舟云学术

Antitubercular nanocarrier monotherapy: Study of In Vivo efficacy and pharmacokinetics for rifampicin

Published:2020-05 Issue: Volume:321 Page:312-323
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Trousil Jiří,Pavliš Oto,Kubíčková Pavla,Škorič Miša,Marešová Věra,Pavlova Ewa,Knudsen Kenneth D.,Dai You-Shan,Zimmerman Matthew,Dartois Véronique,Fang Jia-You,Hrubý Martin

Funder

Charles University

Czech Science Foundation

Ministry of Education, Youth and Sports of the Czech Republic

National sustainability program I

Research Council of Norway

Czech Academy of Sciences

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference45 articles.

1. The potential advantages of nanoparticle drug delivery Systems in Chemotherapy of tuberculosis;Gelperina;Am. J. Respir. Crit. Care Med.,2005

2. New old challenges in tuberculosis: potentially effective nanotechnologies in drug delivery;Sosnik;Adv. Drug Deliv. Rev.,2010

3. Novel nanoparticle delivery systems for rifampicin: an effective strategy against tuberculosis?;Trousil;Nanomedicine (London),2017

4. Global Tuberculosis Report 2016;WHO,2017

5. Advances in the development of new tuberculosis drugs and treatment regimens;Zumla;Nat. Rev. Drug Discov.,2013

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Breaking barriers: The potential of nanosystems in antituberculosis therapy;Bioactive Materials;2024-09

2. Cascade-targeting polymeric particles eliminate intracellular C. neoformans in fungal infection therapy;Journal of Controlled Release;2024-09

3. Novel strategies based on natural products and synthetic derivatives to overcome resistance in Mycobacterium tuberculosis;European Journal of Medicinal Chemistry;2024-04

4. A disulfide molecule–vancomycin nanodrug delivery system efficiently eradicates intracellular bacteria;Journal of Materials Chemistry B;2024

5. Development of a HPLC Method for Analysis of a Combination of Clofazimine, Isoniazid, Pyrazinamide, and Rifampicin Incorporated into a Dermal Self-Double-Emulsifying Drug Delivery System;Methods and Protocols;2023-11-01